KNTE
Kinnate Biopharma Inc
Price:  
2.65 
USD
Volume:  
2,812,220.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KNTE Relative Valuation

-2015.0%
Upside

As of 2025-07-08, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (50.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2015.0%.

The range of the Relative Valuation is (32.00) - (63.52) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.9x - 26.6x 19.8x
Forward P/E multiples 13.4x - 32.1x 22.8x
Fair Price (32.00) - (63.52) (50.75)
Upside -1307.6% - -2497.1% -2015.0%
2.65 USD
Stock Price
(50.75) USD
Fair Price

KNTE Relative Valuation - Historical P/E Data

Date P/E